0000849146-24-000033.txt : 20240403 0000849146-24-000033.hdr.sgml : 20240403 20240403171254 ACCESSION NUMBER: 0000849146-24-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aure Carl CENTRAL INDEX KEY: 0001891462 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 24819992 MAIL ADDRESS: STREET 1: 3300 N. TRIUMPH BLVD., SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900224471 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 4 1 wk-form4_1712178764.xml FORM 4 X0508 4 2024-04-01 0 0000849146 Lifevantage Corp LFVN 0001891462 Aure Carl 3300 N. TRIUMPH BLVD SUITE 700 LEHI UT 84043 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-04-01 4 M 0 2401 0 A 129409 D Common Stock 2024-04-01 4 F 0 1989 6.39 D 127420 D Performance Restricted Stock Units 2024-04-01 4 M 0 2401 0 D Common Stock 2401 12005 D On August 18, 2022, the reporting person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the Issuer, as follows: (i) 1/3 of the earned award vested on the first anniversary of the grant date and (ii) an additional 1/12 of the earned award will vest on the first day of each calendar quarter thereafter. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target; accordingly, the reporting person is eligible to earn 133.13% of the target number of units. The actual number of shares that vested on the reported transaction date was 133.13% of the at-target number of shares subject to vesting on that date and the number of PSUs beneficially owned following the reported transaction has been updated to reflect the new target number of units. Includes 1,805 total shares purchased under the Issuer's 2019 Employee Stock Purchase Plan on February 29, 2024. These shares were withheld to satisfy tax withholding obligations in connection with the vesting Performance Restricted Stock Unit ("PSU") awards and stock unit awards granted to the reporting person on August 18, 2022. PSUs convert into common stock on a one-for-one basis. Alissa Neufeld, Power of Attorney for Carl Aure 2024-04-03